Follow us on Twitter
twitter icon@FreshPatents


Vasocon patents

      

This page is updated frequently with new Vasocon-related patent applications.




 Control of blood vessel physiology to treat skin disorders patent thumbnailControl of blood vessel physiology to treat skin disorders
In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, e.g., by inducing ischemia, of the at least one abnormal blood vessel. A vasoconstriction composition can then be applied to the skin region to cause vasoconstriction of the at least one blood vessel in order to promote healing..
Biochemics, Inc.


 Arthroscopic irrigation solution and  peripheral vasoconstriction and inhibition of pain and inflammation patent thumbnailArthroscopic irrigation solution and peripheral vasoconstriction and inhibition of pain and inflammation
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that demonstrates substantial agonist activity at alpha adrenergic receptors and that is selected for peripheral (local) vasoconstriction and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution.

 Novel hemostatic patch and uses thereof patent thumbnailNovel hemostatic patch and uses thereof
Disclosed herein is a novel hemostatic patch that may be used to control and/or arrest bleeding in patients. The patch offers an effective but also minimally invasive way to control and/or arrest bleeding in a patient.

 Non-flushing niacin analogues, and methods of use thereof patent thumbnailNon-flushing niacin analogues, and methods of use thereof
One aspect of the present invention relates to substituted pyridines and pharmaceutically acceptable salts thereof that are active against a range of mammalian maladies. Another aspect of the invention relates to a pharmaceutical composition, comprising a compound of the present invention or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable excipient.
Trustees Of Tufts College


 Methods for treating pulmonary hypertension patent thumbnailMethods for treating pulmonary hypertension
The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting adp-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible p2y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments..
The Medicines Company


 Composition and  treating nosebleeds patent thumbnailComposition and treating nosebleeds
A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline.
Binyarco, Llc


 Arthroscopic irrigation solution and  peripheral vasoconstriction and inhibition of pain and inflammation patent thumbnailArthroscopic irrigation solution and peripheral vasoconstriction and inhibition of pain and inflammation
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution.
Omeros Corporation


 Therapeutic suit patent thumbnailTherapeutic suit
The therapeutic suit reliefs joint pain by applying heat or cold relief to one or all joints of the body and bringing healing to joints by vasoconstriction, centralizing oxygenated blood around the joints during cold therapy treatment.. .

 Method and system for providing an early risk recognition monitoring patent thumbnailMethod and system for providing an early risk recognition monitoring
A system for providing an early risk recognition monitoring by measurement of a peripheral tissue perfusion of a patient instead of clinically significant changes in systemic blood pressure and/or blood flow comprises a wristband device for gathering measurement data of the patient. The device measures a first temperature (t1) of the patient at the first wrist (or distal antebrachium) point and a second temperature (t2) of the patient at the second finger point, whereupon the system determines altered peripheral tissue perfusion by determining temperature gradient (Δt) between said first and second points.
Medieta Oy


 Arthroscopic irrigation solution and  peripheral vasoconstriction and inhibition of pain and inflammation patent thumbnailArthroscopic irrigation solution and peripheral vasoconstriction and inhibition of pain and inflammation
A method and solution for perioperatively inhibiting a variety of pain and inflammation processes during arthroscopic procedures. The solution preferably includes a vasoconstrictor that exhibits alpha-adrenergic activity and one or more additional pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated ringer's solution.
Omeros Corporation


Salvinorin compositions and uses thereof

The invention relates to salvinorin compositions and uses thereof. Specifically, the invention relates to administering salvinorin compositions to treat diseases and disorders associated with vasoconstriction, vaso-occlusion, or disruption of blood flow and autoregulation.
The Trustees Of The University Of Pennsylvania

Composition for prevention of vasoactivity in the treatment of blood loss and anemia

The present invention relates to the prevention of cardiovascular and central nervous system side effects in mammals who receive transfusions of hemoglobin based oxygen carriers (hboc) or stored blood products containing a concentration of hemoglobin sufficient to induce vasoconstriction, by adding a vasoactivity reducing effective amount of one or more phosphodiesterase inhibitors in combination with a calcium channel blocker and/or an alpha agonist, to the circulation, or alternatively to the hboc or stored blood, thereby preventing the manifestation of vasoactivity attributable to the presence of free tetrameric hemoglobin (hb).. .

Cyanocobalamin, methylcobalamin, and/or adenosylcobalamin to help maintain a pain-free head and pain-free body and provide defense against headaches and body pain

The current invention discloses novel approaches to help individuals defend against headaches and body pains with orally-delivered cyanocobalamin, methylcobalamin, adenosylcobalamin, and combinations thereof. Original clinical research conducted by the inventor on almost 2,000 humans yielded surprising and unexpected results showing differences in the frequency and severity of pains in the head and the body favoring cyanocobalamin patients over placebo.

No/nitrogen gaseous mixture with a high no content for the treatment of severe hypoxemic respiratory failure

The invention concerns a gaseous medicine comprising a mixture of nitrogen monoxide (no) and nitrogen (n2) for use by inhalation for the treatment of hypoxemic respiratory failure linked to pulmonary vasoconstriction in humans, said gaseous mixture containing between 1200 and 4500 ppm by volume (ppmv) of nitrogen monoxide (no) and said hypoxemic respiratory failure being chosen from acute respiratory distress syndrome (ards) or persistent pulmonary hypertension of the newborn infant (pphn).. .
Air Liquidee Sante (international)

Compositions and methods for modulation of vascular structure and/or function

The present invention relates to compositions comprising semi-crystalline β-1-4-n-acetylglucosamine polymers (p-glcnac) and methods utilizing such polymers modulation of vascular structure and/or function. The compositions and methods disclosed are useful for stimulating, in a p-glcnac concentration-dependent manner, endothelin-1 release, vasoconstriction, and/or reduction in blood flow out of a breached vessel, as well as for contributing to or effecting cessation of bleeding.
Marine Polymer Technologies, Inc.

Monitoring cardiovascular conditions using signal transit times

Methods for monitoring cardiovascular conditions, i.e., hyperdynamic circulation, vasodilation, vasoconstriction, or central-to-peripheral arterial pressure decoupling conditions are described. These methods involve measuring a central signal proportional to or a function of the subject's heart activity and a peripheral signal proportional to or a function of a signal related to the central signal.
Edwards Lifesciences Corporation

Non-flushing niacin analogues, and methods of use thereof

One aspect of the present invention relates to substituted pyridines and pharmaceutially acceptable salts thereof that are active against a range of mammalian maladies. Another aspect of the invention relates to a pharmaceutical composition, comprising a compound of the present invention or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable excipient.
Trustees Of Tufts College

Method for producing no/n2 gaseous mixtures intended for the medical field

The invention relates to a method for producing an no/n2 gaseous mixture, comprising the steps of effecting a purification of impure gaseous nitrogen containing impurities at least of the o2 type by putting the impure nitrogen in contact with a catalyst and then with a molecular sieve; mixing the pure nitrogen obtained with nitric oxide (no), and obtaining a mixture formed from no and pure nitrogen containing an no content of less than 20% by volume and a proportion of impurities of the o2 type of less than 5 ppmv and of the h2o type of less than 40 ppmv. The no/nitrogen mixture may undergo supplementary dilutions with pure nitrogen.
Air Liquide Santé (international)

Thermal grill for body cooling and driver alertness

A system for keeping a driver alert by employing a thermal grill that includes warm and cool regions. The system includes an alert module that configures the thermal grill to a heat sink configuration and a heat source configuration.

Novel hemostatic patch and uses thereof

Disclosed herein is a novel hemostatic patch that may be used to control and/or arrest bleeding in patients. The patch offers an effective but also minimally invasive way to control and/or arrest bleeding in a patient.

Implantable device with responsive vascular and cardiac controllers

Exemplary methods are described for providing responsive vascular control with or without cardiac pacing. An implantable device with responsive vascular and cardiac controllers interprets physiological conditions and responds with an appropriate degree of vascular therapy applied as electrical pulses to a sympathetic nerve.

Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto

That are useful in methods of treatment and alleviation of diseases and disorders of the heart, brain, kidney, immune, and reproductive system resulting from ischemia, or reperfusion subsequent to ischemia, and any downstream complication(s) related thereto. The present invention further relates to methods of treatment and alleviation of diseases and disorders of the vasculature resulting from vasoconstriction or hypertension and any downstream complication(s) resulting from elevated blood pressure and/or reduced tissue perfusion..

Closed loop chronic electroacupuncture system using changes in body temperature or impedance

A closed loop electroacupuncture (ea) system monitors any change in sympathetic drive within the body of a patient undergoing ea stimulation. The sensed change in sympathetic drive is then used to adjust at least one parameter of the ea stimulation regimen in an appropriate manner that assists regulation of the patient's autonomic nervous system (ans).

Therapeutic compositions

The invention relates to a product containing the compound of formula (i) below (i) or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having pde5-inhibitory properties, or a pharmaceutically acceptable salt thereof, for therapeutic use, simultaneously, separately or over a period of time, in the treatment of a disease wherein vasoconstriction is involved.. .

Methods for treating pulmonary hypertension

The present invention relates to methods for treating or preventing pulmonary hypertension, reducing mortality in a subject experiencing pulmonary hypertension, or inhibiting adp-mediated vasoconstriction of pulmonary arteries in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a reversible p2y12 receptor antagonist. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments..





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Vasocon for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vasocon with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.6519

file did exist - 1297

1 - 1 - 25